Secondary imatinib resistance associated with an aberrant bcr-abl fusion gene

JJWM Janssen, A Hochhaus, JW van Oostveen, Q Waisfisz, GJ Schuurhuis, GJ Ossenkoppele

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Pages (from-to)1020-1021
JournalLeukemia
Volume18
Issue number5
DOIs
Publication statusPublished - May 2004

Cite this

@article{c9e004369a874786b91d7290515192c8,
title = "Secondary imatinib resistance associated with an aberrant bcr-abl fusion gene",
author = "JJWM Janssen and A Hochhaus and {van Oostveen}, JW and Q Waisfisz and GJ Schuurhuis and GJ Ossenkoppele",
year = "2004",
month = "5",
doi = "10.1038/sj.leu.2403338",
language = "English",
volume = "18",
pages = "1020--1021",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "5",

}

Secondary imatinib resistance associated with an aberrant bcr-abl fusion gene. / Janssen, JJWM; Hochhaus, A; van Oostveen, JW; Waisfisz, Q; Schuurhuis, GJ; Ossenkoppele, GJ.

In: Leukemia, Vol. 18, No. 5, 05.2004, p. 1020-1021.

Research output: Contribution to journalLetterAcademicpeer-review

TY - JOUR

T1 - Secondary imatinib resistance associated with an aberrant bcr-abl fusion gene

AU - Janssen, JJWM

AU - Hochhaus, A

AU - van Oostveen, JW

AU - Waisfisz, Q

AU - Schuurhuis, GJ

AU - Ossenkoppele, GJ

PY - 2004/5

Y1 - 2004/5

U2 - 10.1038/sj.leu.2403338

DO - 10.1038/sj.leu.2403338

M3 - Letter

VL - 18

SP - 1020

EP - 1021

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 5

ER -